Related Experiment Video
Updated: Feb 7, 2026

22:06
Derivation of Hematopoietic Stem Cells from Murine Embryonic Stem Cells
Published on: February 25, 2007
14.0K
Differentiation-based model of hematopoietic stem cell functions and lineage pathways
Thomas Höfer1,2, Hans-Reimer Rodewald3
1Division of Theoretical Systems Biology, German Cancer Research Center, Heidelberg, Germany.
Blood
|July 26, 2018
Summary
New genetic tools reveal how hematopoietic stem cells (HSCs) produce blood cells. These methods track HSCs in situ, showing how they differentiate and self-renew to maintain the blood system.
Area of Science:
- Hematopoiesis and Stem Cell Biology
- Molecular Genetics and Epigenetics
Background:
- Traditional methods for studying hematopoietic stem cells (HSCs) relied on proliferation assays and transplanted cell fates.
- Recent advances in genetic labeling and barcoding allow for in situ analysis of HSCs and their progeny.
- Existing data suggest a specific phenotype for tip HSCs, but their precise contribution to hematopoiesis requires further elucidation.
Purpose of the Study:
- To leverage novel genetic labeling and barcoding techniques to directly measure the quantitative and qualitative output of hematopoietic stem cells (HSCs) in situ.
- To investigate the kinetics of label emergence in downstream compartments to determine rates of differentiation and self-renewal.
- To probe precursor-product relationships within the hematopoietic system using endogenous HSC barcoding.
Main Methods:
- Insertion of heritable genetic labels at various stages of hematopoietic differentiation.
- Measurement of label kinetics in downstream cellular compartments to infer differentiation and self-renewal rates.
- Endogenous HSC barcoding to map physiological precursor-product relationships.
- Analysis of tip HSC phenotype (Tie2) and their contribution to hematopoiesis through fate mapping.
Main Results:
- Genetic labeling and barcoding enable direct, in situ measurement of HSC output, revealing differentiation and self-renewal dynamics.
- Tip HSCs (Tie2 phenotype) were observed to contribute to downstream lineages, though individual cells participate infrequently.
- Progenitor cells downstream of tip HSCs represent a major, self-renewing source for daily hematopoiesis, making the system temporarily HSC-independent.
- HSCs can produce multilineage output, but lineage-restricted fates, including single-lineage commitment, were also observed.
- Clone-specific fates were identified in single HSCs derived from fetal precursors within the bone marrow.
Conclusions:
- Novel in situ tools for probing HSC differentiation offer a more dynamic and accurate understanding compared to traditional assays.
- The findings challenge previous interpretations of single-cell gene expression snapshots regarding lineage commitment.
- Integrating in vivo fate analyses with molecular data is crucial for deciphering the mechanisms of lineage commitment and the architecture of physiological hematopoiesis.
Related Concept Videos
Multipotency of Hematopoietic Stem Cells
3.9K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.9K
Regulation of Hematopoietic Stem Cells
4.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.1K
Adult Stem Cells
33.9K
Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.9K
Embryonic Stem Cells
32.5K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.5K
Induced Pluripotent Stem Cells
28.1K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.1K
Lineage Commitment
4.4K
Commitment is the process whereby stem cells:
4.4K

